share_log

Acurx Pharmaceuticals | 8-K: Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update

SEC ·  Nov 15, 2023 05:05
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.